Hong Kong Healthcare Services Stock News

Latest Results Set the Stage for SJM Holdings’ Next Chapter SJM Holdings (SEHK:880) has posted its FY 2025 first half results with revenue of HK$14.6b and a basic EPS loss of HK$0.026, while the trailing twelve months show revenue of HK$29.6b and a basic EPS loss of HK$0.002. Over recent periods the company has seen revenue range between HK$13.8b and HK$15.0b per half year, with basic EPS moving between a loss of HK$0.023 and a profit of HK$0.023 as the business works through uneven...

Newborn Town (SEHK:9911) has drawn fresh investor attention after issuing a positive profit alert, highlighting substantial gains in revenue and profits, wider AI use across its platforms, share buybacks and inclusion in the Hang Seng Composite Index. See our latest analysis for Newborn Town. Despite the upbeat profit alert and index inclusion, Newborn Town’s 1 month share price return of a 10.59% decline and year to date share price return of a 22.49% decline suggest momentum has cooled...

JD Health International (SEHK:6618) opened FY 2025 with first half revenue of C¥35.3b and basic EPS of C¥0.82, setting the tone after a trailing twelve month period that closed with revenue of C¥73.4b and EPS of C¥1.70. The company has seen revenue step up from C¥28.3b in the first half of FY 2024 to C¥29.8b in the second half and then to C¥35.3b in the latest half, while basic EPS moved from C¥0.65 to C¥0.68 and now C¥0.82, giving investors a clearer view of how higher sales are flowing...

JD Logistics (SEHK:2618) has wrapped up FY 2025 with fourth quarter revenue of C¥63.5b, Basic EPS of C¥0.32 and net income excluding extra items of C¥2.0b, setting a clear headline for its latest earnings season update. The company has seen quarterly revenue move from C¥52.1b in Q4 2024 to C¥63.5b in Q4 2025. Trailing twelve month revenue reached C¥217.1b and net income excluding extra items came in at C¥6.6b, giving investors a fuller view of scale and consistency. With a current net profit...

Board meeting puts Giant Biogene’s 2025 results and dividend plans in focus Giant Biogene Holding (SEHK:2367) has called a board meeting for 19 March 2026 to approve its audited 2025 annual results and consider recommending a final dividend, a key calendar point for shareholders. See our latest analysis for Giant Biogene Holding. Despite a 2.49% 1 day share price return lifting the stock to HK$30.5, the 30 day share price return of 5.10% and 1 year total shareholder return of 54.97% decline...

China Resources Power Holdings (SEHK:836) has scheduled a board meeting for 18 March 2026 to approve its 2025 annual results and consider a final dividend recommendation, marking an important date for investors focused on shareholder returns. See our latest analysis for China Resources Power Holdings. Recent trading has been firm, with a 1-day share price return of 1.53% and 1-month share price return of 7.57% at HK$18.61. The 1-year total shareholder return of 8.55% and 5-year total...

China Medical System Holdings (SEHK:867) has received National Medical Products Administration approval to begin clinical trials for CMS-D008, an siRNA therapy targeting INHBE in overweight and obese individuals and using a mechanism that is different from GLP-1RAs. See our latest analysis for China Medical System Holdings. The CMS-D008 trial approval lands after a choppy stretch for the shares, with a 7 day share price return of 11.14% decline and a 30 day share price return of 10.22%...

Prada Group (SEHK:1913) has fully integrated Versace into its operations, reshaping the luxury house within the wider group structure. The group has ended the Versace Jeans Couture line as part of a broader refresh of brand positioning. New creative leadership at Versace and fresh investment in digital technology and AI tools are reshaping how the group runs its brands. MIU MIU continues to play an important role in the group, alongside the changes at Versace and ongoing digital...

Prada (SEHK:1913) has reported full year 2025 results with sales of €5,572.51 million, revenue of €5,717.52 million and net income of €851.94 million, giving investors fresh data on recent performance. See our latest analysis for Prada. The full year 2025 results land after a busy stretch for Prada, including a €300 million senior unsecured bond issue in February. The stock has seen a 9.93% 1 month share price return but a 31.53% 1 year total shareholder return decline, suggesting short term...

China's National Development and Reform Commission has announced a policy to boost intellectual property driven consumer spending. The policy aims to deepen collaborations between consumer brands and well known IPs across toys, entertainment and retail. Pop Mart International Group (SEHK:9992), a major player in branded collectibles, is directly exposed to this policy shift. The move is designed to support consumption and IP commercialization within China, with implications for both domestic...

Recent share performance and business snapshot Zhongsheng Group Holdings (SEHK:881) has been under pressure recently, with the share price showing negative returns over the past week, month, past 3 months, year, and on a 3 year and 5 year view. At a last close of HK$9.41, the company sits against a backdrop of HK$163,024.88m in revenue and HK$2,643.99m in net income. Annual revenue and net income growth figures are moving in different directions. See our latest analysis for Zhongsheng Group...

Why Kingboard Holdings just moved back onto investors’ radar Kingboard Holdings (SEHK:148) issued fresh earnings guidance for 2025, telling investors it expects net profit of more than HK$4.32b, over 165% higher than the prior year. The company links this jump mainly to its investment segment and its laminates business, where robust demand and higher unit prices for laminates and upstream materials such as fibreglass yarn, fibreglass fabric and copper foil have coincided with greater sales...

Akeso (SEHK:9926) reported long term survival data for cadonilimab in advanced cervical cancer, with benefits extending to patients who are PD L1 negative or resistant to prior therapies. The company also entered a collaboration with INOVIO to study a combination immunotherapy approach for glioblastoma. Akeso focuses on immuno oncology drugs, and cadonilimab is one of its key assets in gynecologic cancers. The fresh data around long term outcomes in advanced cervical cancer reinforces the...

Shanghai Electric Group (SEHK:2727) is back in focus after supplying core equipment to the Huai'an Salt Cavern compressed air energy storage project in Jiangsu, which is now fully commissioned as the world's largest CAES station. See our latest analysis for Shanghai Electric Group. The Huai'an CAES milestone and the recent board changes come against a backdrop of strong share price momentum, with a 1 day share price return of 15.76% helping lift the 30 day share price return to 18.27%. The 1...

BYD (SEHK:1211) has launched a new electric vehicle battery that it says can fully charge in 9 minutes. The company is moving ahead with plans to buy a large manufacturing facility in Mexico to support international growth. These moves come as BYD faces sharp sales declines in its home market and softer demand in China. BYD shares last closed at HK$92.6, with the stock down 22.3% over the past year but up 46.3% over five years. That mixed record shows how investor sentiment around SEHK:1211...

Recent performance snapshot China Petroleum & Chemical (SEHK:386) has caught investor attention after a mixed run, with the share price showing a 2.1% decline over the past day and a 4.2% decline over the past week. Over a longer stretch, the stock shows a 2.3% decline over the past month, a 14.8% gain over the past 3 months, a 10.6% return year to date, and a 32.3% total return over the past year. See our latest analysis for China Petroleum & Chemical. With the share price at HK$5.2, the...

Hong Kong Exchanges and Clearing Limited recently reported its fourth-quarter and full-year 2025 results, posting revenue of HK$7,310 million for the quarter and HK$29.16 billion for the year, alongside net income of HK$4,335 million and HK$17.75 billion respectively, and announced the appointment of Mr. Clement Chan to its Board from the 2026 AGM. Alongside these results, the Board raised the ordinary second interim dividend to HK$6.52 per share and signalled boardroom continuity by naming...

What the latest earnings tell you about Great Eagle Holdings Great Eagle Holdings (SEHK:41) has drawn fresh attention after releasing its full year 2025 results, with higher reported sales and a smaller net loss that give investors more current financial reference points. See our latest analysis for Great Eagle Holdings. The earnings release has landed against a backdrop of stronger recent share price momentum, with a 16.64% 90 day share price return and a 59.53% 1 year total shareholder...

Why Zhejiang Leapmotor Technology (SEHK:9863) is Drawing Investor Attention Now Zhejiang Leapmotor Technology (SEHK:9863) has been on investors’ radars recently as its share price reflects mixed return figures across the past week, month and past 3 months, prompting closer attention to fundamentals and expectations. See our latest analysis for Zhejiang Leapmotor Technology. Despite the recent 7 day share price return of 7.06% decline and a 90 day share price return of 27.23% decline, the...

Why Geely Automobile Holdings Is Back on Investors’ Radar Geely Automobile Holdings (SEHK:175) is drawing fresh attention after outpacing BYD in vehicle deliveries for a second straight month. Its Waymo Robotaxi partnership and growing Gen Z interest highlight new demand channels. See our latest analysis for Geely Automobile Holdings. At around HK$15.16, Geely Automobile Holdings has a 1 day share price return of 0.20%, while its 30 day and year to date share price returns of 4.23% and 16.70%...

ASMPT (SEHK:522) has released its FY 2025 numbers with third quarter revenue at HK$3.7b and a basic EPS loss of HK$0.65, alongside trailing 12 month EPS of HK$2.61 on revenue of HK$13.7b. The company has seen quarterly revenue move from HK$3.3b in Q2 2024 to HK$3.4b in Q2 2025, while basic EPS shifted from HK$0.33 to HK$0.32 over the same quarters, presenting solid sales with more volatile earnings. For investors, the key question is how durable the current 7.9% trailing net margin looks...

What DPC Dash’s Share Performance Is Signalling DPC Dash (SEHK:1405) has been under pressure, with the share price showing a 0.6% decline over the past day, 4.2% over the past week, roughly 3% over the past month, and 22.5% over the past 3 months. Over the past year, investors have faced a total return decline of 39.9%, even as the company reports annual revenue of CN¥4,866.022 and net income of CN¥110.212, with the stock trading around HK$62 at the last close. See our latest analysis for DPC...

Uni-President China Holdings (SEHK:220) posts steady FY 2025 first half results Uni-President China Holdings (SEHK:220) has put fresh numbers on the table for FY 2025 first half, with revenue of about C¥17.1b and basic EPS of C¥0.30, giving investors a clear read on how the business is performing heading into the rest of the year. The company has seen revenue move from roughly C¥14.9b in 2024 second half and C¥15.4b in 2024 first half to C¥17.1b in the latest period. Basic EPS shifted from...

Legend Holdings (SEHK:3396) shares are in focus after the company projected 2025 net profit of at least CN¥900 million, based on preliminary figures that mark a sharp rebound from 2024’s CN¥133 million. See our latest analysis for Legend Holdings. The shares reacted quickly to the profit guidance, with a 1 day share price return of 6.26% helping to lift the 30 day share price return to 9.24%. However, the 1 year total shareholder return is slightly negative at 0.32% and the longer term 5 year...